tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
Advertisement

Genmab (GMAB) Technical Analysis

Compare
667 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Genmab A/S’s (GMAB) Moving Averages Convergence Divergence (MACD) indicator is 0.63, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GMAB) 20-Day exponential moving average is 22.96, while Genmab A/S’s (GMAB) share price is $24.65, making it a Buy.
Genmab A/S’s (GMAB) 50-Day exponential moving average is 22.21, while Genmab A/S’s (GMAB) share price is $24.65, making it a Buy.

Genmab (GMAB) Pivot Points

Aug 24, 2025, 05:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.15
24.23
24.32
24.41
24.50
24.58
24.68
Fibonacci
24.23
24.30
24.34
24.41
24.47
24.52
24.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab (GMAB) Moving Averages

Aug 24, 2025, 05:00 PM
Period
Simple
Exponential
MA5
24.07Buy
24.09Buy
MA10
23.23Buy
23.53Buy
MA20
22.67Buy
22.96Buy
MA50
22.01Buy
22.21Buy
MA100
21.16Buy
21.76Buy
MA200
21.12Buy
21.92Buy
Genmab A/S’s (GMAB) 10-Day exponential moving average is 23.53, while Genmab A/S’s (GMAB) share price is $24.65, making it a Buy.
Genmab A/S’s (GMAB) 100-Day exponential moving average is 21.76, while Genmab A/S’s (GMAB) share price is $24.65, making it a Buy.
Genmab A/S’s (GMAB) stock price is $24.65 and Genmab A/S’s (GMAB) 50-day simple moving average is 22.01, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $24.65 and Genmab A/S’s (GMAB) 100-day simple moving average is 21.16, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $24.65 and Genmab A/S’s (GMAB) 200-day simple moving average is 21.12, creating a Buy signal.

Genmab (GMAB) Technical Indicators

Aug 24, 2025, 05:00 PM
Name
Value
Implied Action
RSI (14)
67.82
Neutral
STOCH (9,6)
94.44
Sell
STOCHRSI (14)
94.51
Sell
MACD (12,26)
0.63
Sell
ADX (14)
23.16
Neutral
Williams %R
-4.82
Sell
CCI (14)
155.47
Sell
ATR (14)
0.57
-
Ultimate Oscillator
64.34
Neutral
ROC
12.15
Buy
Genmab A/S’s (GMAB) Relative Strength Index (RSI) is 67.82, creating a Neutral signal.
Genmab A/S’s (GMAB) Trend Strength Indicator (ADX) is 23.16, creating a Neutral signal.
Genmab A/S’s (GMAB) Commodity Channel Index (CCI) is 155.47, creating a Sell signal.
Genmab A/S’s (GMAB) Price Rate of Change (ROC) is 12.15, creating a Buy signal.

FAQ

Is GMAB a Buy, Hold, or Sell?
Based on GMAB’s technical indicators, GMAB is a Buy.
    What is GMAB’s RSI (14)?
    GMAB’s RSI (14) is 67.82, which suggests GMAB is a Neutral.
      What is GMAB’s MACD?
      GMAB’s MACD is 0.63, which suggests GMAB is a Sell.
        What is GMAB’s 5-day moving average?
        GMAB’s 5-day moving average is 24.07, which suggests GMAB is a Buy.
          What is GMAB’s 20-day moving average?
          GMAB 20-day moving average is 22.67, which suggests GMAB is a Buy.
            What is GMAB’s 50-day moving average?
            GMAB’s 50-day moving average is 22.01, which suggests GMAB is a Buy.
              What is GMAB’s 200-day moving average?
              GMAB’s 200-day moving average is 21.12, which suggests GMAB is a Buy.
                What is GMAB’s Williams % R (14)?
                GMAB’s Williams % R (14) is -4.82, which suggests GMAB is a Sell.
                  What is GMAB’s CCI (14)?
                  GMAB’s CCI (14) is 155.47, which suggests GMAB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis